DOCUMENTS

papers

Clinical outcomes after bariatric surgery: a five-year matched cohort analysis in seven US states

Published: May 1, 2012
Category: Bibliography > Papers
Authors: Bolen SD, Chang HY, Clark JM, Goodwin SM, Johns RA, Magnuson TH, Richards TM, Shore AD, Weiner JP
Countries: United States
Language: null
Types: Population Health
Settings: Academic

Obes Surg 22:749-763.

Center for Health Care Research and Policy, MetroHealth Medical Center/Case Western Reserve University, Cleveland, OH, USA

BACKGROUND: Bariatric surgery is the most effective weight loss treatment, yet few studies have reported on short- and long-term outcomes postsurgery.

METHODS: Using claims data from seven Blue Cross/Blue Shield health plans serving seven states, we conducted a non-concurrent, matched cohort study. We followed 22,693 persons who underwent bariatric surgery during 2003-2007 and were enrolled at least 6 months before and after surgery. Using logistic regression, we compared serious and less serious adverse clinical outcomes, hospitalizations, planned procedures, and obesity-related co-morbidities between groups for up to 5 years.

RESULTS: Relative to controls, surgery patients were more likely to experience a serious [odds ratio (OR) 1.9; 95% confidence interval (CI) 1.8-2.0] or less serious (OR 2.5, CI 2.4-2.7) adverse clinical outcome or hospitalization (OR 1.3, CI 1.3-1.4) at 1 year postsurgery. The risk remained elevated until 4 years postsurgery for serious events and 5 years for less serious outcomes and hospitalizations. Some complication rates were lower for patients undergoing laparoscopic surgery. Planned procedures, such as skin reduction, peaked in postsurgery year 2 but remained elevated through year 5. Surgery patients had a 55% decreased risk of obesity-related co-morbidities, such as type 2 diabetes, in the first year postsurgery, which remained low throughout the study (year 5: OR 0.4, CI 0.4-0.5).

CONCLUSIONS: While bariatric surgery is associated with a higher risk of adverse clinical outcomes compared to controls, it also substantially decreased obesity-related co-morbidities during the 5-year follow-up.

PMID: 22271357

Co-morbidity,High Risk,Outcome Measures,Predictive Risk Models,United States,Adolescent,Adult,Aged,Cohort Studies,Follow-Up Studies,Hospitalization/statistics & numerical data,Logistic Models,Middle Aged,Gender,Obesity,Morbid/epidemiology,Obesity,Morbid/rehabilitation,Postoperative Complications/epidemiology,Postoperative Complications/etiology,Treatment Outcome,United States/epidemiology,Young Adult

Please log in/register to access.

Log in/Register

LinkedIn Facebook Twitter

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System.
All rights reserved. Terms of Use Privacy Statement

Back to top